Gilead announces new sustained viral response data for Sofosbuvir based regimens in genotype 3-infected Hepatitis C patients
“The VALENCE results demonstrate the high efficacy of a 24-week,…
2 November 2013 | By Creston Health
“The VALENCE results demonstrate the high efficacy of a 24-week, sofosbuvir-based, interferon-free treatment regimen for genotype 3 HCV patients..."